FilingSEC EDGAR8-K
Senti Biosciences Adjourns Annual Meeting
· SEC accepted
StageMeeting Adjournment
Filing content
Senti Biosciences adjourned its 2026 annual meeting to solicit further votes for the merger agreement proposal, with the meeting to be reconvened on October 15, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…